Results 131 to 140 of about 60,842 (297)

Clinical findings in relation to mortality in non-tuberculous mycobacterial infections : patients with Mycobacterium avium complex have better survival than patients with other mycobacteria [PDF]

open access: yes, 2015
We compared the clinical findings and survival in patients with Mycobacterium avium complex (MAC) and other non-tuberculous mycobacteria (NTM). A total of 167 adult non-human immunodeficiency virus (HIV) patients with at least one positive culture for ...
Eskola, J.   +5 more
core   +1 more source

Comprehensive subspecies identification of 175 nontuberculous mycobacteria species based on 7547 genomic profiles

open access: yesEmerging Microbes and Infections, 2019
The prevalence of nontuberculous mycobacteria (NTM) pulmonary diseases has been increasing worldwide. NTM consist of approximately 200 species and distinguishing between them at the subspecies level is critical to treatment.
Y. Matsumoto   +9 more
semanticscholar   +1 more source

Dry pleurisy complicating solitary pulmonary nodules caused by Mycobacterium avium: a case report [PDF]

open access: yes, 2015
INTRODUCTION: Mycobacterium avium complex (MAC) lung disease presenting as a solitary pulmonary nodule (MAC-SPN) is often asymptomatic, is more common in middle to old age, and mimics lung cancer or tuberculoma.
Hiroaki Sugiura   +14 more
core   +1 more source

Global Environmental Nontuberculous Mycobacteria and Their Contemporaneous Man-Made and Natural Niches

open access: yesFrontiers in Microbiology, 2018
Seminal microbiological work of environmental nontuberculous mycobacteria (NTM) includes the discovery that NTM inhabit water distribution systems and soil, and that the species of NTM found are geographically diverse.
J. Honda, R. Virdi, E. Chan
semanticscholar   +1 more source

Detection and identification of mycobacteria in sputum from suspected tuberculosis patients

open access: yesBMC Research Notes, 2010
Background Detection of Tuberculosis agent like nontuberculous mycobacteria (NTM) species by culture and microscopic methods remains difficult and time consuming.
Yadi   +4 more
doaj   +1 more source

Prolonged Outbreak of Mycobacterium chimaera Infection After Open-Chest Heart Surgery [PDF]

open access: yes, 2017
A thorough epidemiological and microbiological investigation of this prolonged outbreak involving 6 open-chest heart surgery patients provided evidence for the airborne transmission of Mycobacterium chimaera, a slow-growing nontuberculous mycobacteria ...
Achermann, Yvonne   +10 more
core  

Acetic Acid, the Active Component of Vinegar, Is an Effective Tuberculocidal Disinfectant

open access: yesmBio, 2014
Effective and economical mycobactericidal disinfectants are needed to kill both Mycobacterium tuberculosis and non-M. tuberculosis mycobacteria. We found that acetic acid (vinegar) efficiently kills M. tuberculosis after 30 min of exposure to a 6% acetic
Claudia Cortesia   +8 more
doaj   +1 more source

A tuberculosis nationwide prevalence survey in Gambia, 2012. [PDF]

open access: yes, 2016
OBJECTIVE: To estimate the population prevalence of active pulmonary tuberculosis in Gambia. METHODS: Between December 2011 and January 2013, people aged ≥ 15 years participating in a nationwide, multistage cluster survey were screened for active ...
Adetifa, Ifedayo Mo   +15 more
core   +1 more source

Identification of a group of nontuberculous mycobacteria isolated from the South Indian BCG trial area by HPLC [PDF]

open access: yes, 2002
Twenty-five isolates of nontuberculous mycobacteria isolated from the South Indian BCG trial area were analysed by high performance liquid chromatography (HPLC) for mycolic acid pattern. The chromatograms differentiated the isolates into four species,
Daisy Vanitha, J   +4 more
core  

The Italian registry of pulmonary non-tuberculous mycobacteria - IRENE:The study protocol [PDF]

open access: yes, 2018
Background: A substantial increase in pulmonary and extra-pulmonary diseases due to non-tuberculous mycobacteria (NTM) has been documented worldwide, especially among subjects suffering from chronic respiratory diseases and immunocompromised patients.
A. Calcagno   +39 more
core   +4 more sources

Home - About - Disclaimer - Privacy